Literature DB >> 15679486

Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum.

C Arnold1, L Westland, G Mowat, A Underwood, J Magee, S Gharbia.   

Abstract

The rapid technique of pyrosequencing was used to examine 123 samples (in the form of DNA extracts and inactivated sputum) of Mycobacterium spp. Of 99 Mycobacterium tuberculosis samples investigated for single-nucleotide polymorphisms (SNPs), 68% of isoniazid-resistant isolates analysed had an AGC --> ACC mutation in katG at codon 315, resulting in the Ser --> Thr substitution associated previously with isoniazid resistance. Of the rifampicin-resistant isolates, 92% showed SNPs in rpoB at codons 516, 531 or 526. Inactivated sputum samples and DNA extracts could both be analysed by pyrosequencing, and the method was able to differentiate rapidly between the closely related species of the M. tuberculosis complex (M. tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium canetti and Mycobacterium microti), except between M. tuberculosis, M. canetti and one of two M. africanum strains. This low-cost, high-throughput technique could be used as a rapid screen for drug resistance and as a replacement for some of the time-consuming tests used currently for species identification.

Entities:  

Mesh:

Year:  2005        PMID: 15679486     DOI: 10.1111/j.1469-0691.2004.01034.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  24 in total

1.  GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.

Authors:  A Lacoma; N García-Sierra; C Prat; J Maldonado; J Ruiz-Manzano; L Haba; P Gavin; S Samper; V Ausina; J Domínguez
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Call for a quality standard for sequence-based assays in clinical microbiology: necessity for quality assessment of sequences used in microbial identification and typing.

Authors:  Anthony Underwood; Jonathan Green
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

3.  Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology.

Authors:  Pontus Jureen; Lars Engstrand; Solveig Eriksson; Anders Alderborn; Margareta Krabbe; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens.

Authors:  N García-Sierra; A Lacoma; C Prat; L Haba; J Maldonado; J Ruiz-Manzano; P Gavin; S Samper; V Ausina; J Domínguez
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

5.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based single nucleotide polymorphism genotyping assay using iPLEX gold technology for identification of Mycobacterium tuberculosis complex species and lineages.

Authors:  C Bouakaze; C Keyser; A Gonzalez; W Sougakoff; N Veziris; H Dabernat; B Jaulhac; B Ludes
Journal:  J Clin Microbiol       Date:  2011-07-06       Impact factor: 5.948

6.  "Spoligoriftyping," a dual-priming-oligonucleotide-based direct-hybridization assay for tuberculosis control with a multianalyte microbead-based hybridization system.

Authors:  Michel Kiréopori Gomgnimbou; Edgar Abadia; Jian Zhang; Guislaine Refrégier; Stefan Panaiotov; Elizabeta Bachiyska; Christophe Sola
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

7.  GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.

Authors:  A Lacoma; N Garcia-Sierra; C Prat; J Ruiz-Manzano; L Haba; S Rosés; J Maldonado; J Domínguez
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

Review 8.  Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing.

Authors:  Ameeta S Kalokhe; Majid Shafiq; James C Lee; Susan M Ray; Yun F Wang; Beverly Metchock; Albert M Anderson; Minh Ly T Nguyen
Journal:  Am J Med Sci       Date:  2013-02       Impact factor: 2.378

9.  Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.

Authors:  I L Bergval; R N C P Vijzelaar; E R Dalla Costa; A R J Schuitema; L Oskam; A L Kritski; P R Klatser; R M Anthony
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

10.  Pyrosequencing identification of Mycobacterium tuberculosis W-Beijing.

Authors:  Zoheira Djelouadji; Mireille Henry; Amine Bachtarzi; Nadège Foselle; Didier Raoult; Michel Drancourt
Journal:  BMC Res Notes       Date:  2009-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.